Furthermore, as noted by Gao et al., patients with severe COVID-19 who have high NT-pro-BNP levels are more likely to be older, have greater levels of systemic inflammatory markers and heart damage markers, and have a poorer cumulative survival rate. This evidence concerns the gene NPPB and COVID-19.